Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome - Wikidata - wikimedia - TriplyDB

Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome

Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome

http://www.wikidata.org/entity/Q34351978

about

Three decades of beta-lactamase inhibitors Meta-analysis of proportion estimates of Extended-Spectrum-Beta-Lactamase-producing Enterobacteriaceae in East Africa hospitals Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Klebsiella spp.: A Systematic Review and Meta-Analyses Epidemiology and biomolecular characterization of carbapenem-resistant klebsiella pneumoniae in an Italian hospital Beyond Susceptible and Resistant, Part II: Treatment of Infections Due to Gram-Negative Organisms Producing Extended-Spectrum β-Lactamases Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain.Infections caused by multidrug resistant organisms are not associated with overall, all-cause mortality in the surgical intensive care unit: the 20,000 foot view.Can a routine follow-up blood culture be justified in Klebsiella pneumoniae bacteremia? A retrospective case-control study Epidemiology and outcome of Klebsiella species bloodstream infection: a population-based study.Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy.Microbiologic and clinical implications of bacteremia due to extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae with or without plasmid-mediated AmpC beta-lactamase DHA-1.Pyrosequencing-based analysis reveals a novel capsular gene cluster in a KPC-producing Klebsiella pneumoniae clinical isolate identified in Brazil European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia Effect of ceftriaxone on the outcome of murine pyelonephritis caused by extended-spectrum-β-lactamase-producing Escherichia coli.Prevalence of urinary colonization by extended spectrum-beta-lactamase Enterobacteriaceae among catheterised inpatients in Italian long term care facilities.Emergence in Spain of a multidrug-resistant Enterobacter cloacae clinical isolate producing SFO-1 extended-spectrum beta-lactamase Direct RNA-based detection and differentiation of CTX-M-type extended-spectrum β-lactamases (ESBL).Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system Microbiological characteristics of sepsis in a University hospital Rapid detection of ESBL-producing Enterobacteriaceae in blood cultures.Community acquired multi-drug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal.Clinical characteristics of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type β-lactamases.Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.Epidemiology and Burden of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in a Pediatric Hospital in Senegal.Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapy.Detection of extended-spectrum β-lactamase and Klebsiella pneumoniae Carbapenemase genes directly from blood cultures by use of a nucleic acid microarray The continuing challenge of ESBLs.Colonization and persistence of antibiotic-resistant Enterobacteriaceae strains in infants nursed in two neonatal intensive care units in East London, United Kingdom.Clinical and economic impact of common multidrug-resistant gram-negative bacilli Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes.Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy Sepsis Caused by Extended-Spectrum Beta-Lactamase (ESBL)-Positive K. pneumoniae and E. coli: Comparison of Severity of Sepsis, Delay of Anti-Infective Therapy and ESBL Genotype.Screening for Gram-negative bacteria: Impact of preanalytical parameters.Clinical significance of extended-spectrum beta-lactamases.Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital.Current management of bloodstream infections.Genetic Mechanisms of Antimicrobial Resistance of Acinetobacter baumannii.Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis.Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections.

P2860

Q24646623-B858A925-8E56-4141-9597-2A6493224E50 Q26749161-4897FD64-99B1-465D-AA59-DA4F0F15B554 Q26781236-45D7DB1E-4ADD-4D51-BAF2-7D96A5B70359 Q28077354-89F6ACA0-6B71-418E-85B5-98AC00CAB55D Q28249617-38BF5563-C7FA-458A-B80A-9FA39E92D14D Q30235041-E3A9E2C0-5DBB-42F9-BDBC-D39BFF4E7A38 Q30396308-86737DA1-2FD4-4076-84D5-81D5FBE89F48 Q30419577-F341D15F-8CD6-4A78-B58E-07589BB353B5 Q31125767-CBA80549-0E61-42A5-984C-0C67E505BA10 Q33620388-ECECBC0B-83D7-403A-8007-3144C73CD7C6 Q34150900-1D103497-5071-474C-A9FD-D0F03CFEEB26 Q34309633-17C0E6E5-53EF-4D93-BF37-5296C93F45FA Q34375571-997FB6F6-79CC-4C09-9F50-79906CF4885C Q34390823-93A584F6-8381-4F45-9EC7-A5085DE1C4EC Q34597721-EBDD1A96-4984-4B9B-ABB9-ABA7E769517B Q34623275-2E30D458-B723-4E04-86B5-AD02A227E6FC Q34741562-F3FC435E-7CD6-46FC-B7E3-978FF0F857B2 Q35041607-757E2044-D692-4961-B658-E3330A8C371E Q35065875-3E909583-8AD4-4BDD-B8B7-E3AF2BE43EAB Q35101906-574F048C-45DF-4E8E-9C69-34ED0A113E33 Q35130334-03B4A8B2-4DED-4C0E-9D76-18561441C290 Q35559648-FD99D2A7-17A8-4915-95D0-5D29D6360D46 Q35656192-9AAEB94E-2CA6-445B-B8BE-79A74842BF5E Q35840852-743F137D-E8BB-4C17-8CD1-DAAF4AFDE4BA Q35921039-F7866E73-16B6-4A49-A294-579D0104F4CE Q36150730-FAC2F4AE-4F1A-49F7-8250-64BC3538E0FB Q36172336-DB60028E-BDDE-485C-98B6-3EB5DE48C441 Q36449603-FADA027D-E1AB-4DF0-84A1-5960FCF4155C Q36452441-BC935293-D842-43CC-937A-449BDD90746F Q36482801-A2C9A5FD-1EBF-4CB0-A795-4B2AC2145ACC Q36538655-222281D3-4A15-4474-8425-8AAEAA2B5E71 Q36870786-09517A82-726D-436B-B997-797EB788FAC2 Q37114901-D2B85C75-F634-473C-B13D-C272E8261BBE Q37128301-3679B092-FE67-4B06-818B-27AAB56BF700 Q37291354-8279AF60-0E8B-4FD8-9EA2-3A722B3CD6E0 Q37598820-FEE86668-D00E-434A-9191-A0FF1AB4FB01 Q37768418-1B4F75ED-49BA-40AA-B4A2-7CE0E3652A13 Q37838117-44D7D4D0-489A-4D03-94B7-88319FF91C9B Q37991287-4771A1DF-C7E6-4AF3-982D-F0254B030C2C Q38048860-E096390F-D32B-4F30-AB18-5985DEF134EC

P2860

Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome

http://www.wikidata.org/entity/Q34351978

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Bloodstream infections caused ...... emiology, and clinical outcome

@ast

Bloodstream infections caused ...... emiology, and clinical outcome

@en

Bloodstream infections caused ...... emiology, and clinical outcome

@nl

type

label

Bloodstream infections caused ...... emiology, and clinical outcome

@ast

Bloodstream infections caused ...... emiology, and clinical outcome

@en

Bloodstream infections caused ...... emiology, and clinical outcome

@nl

prefLabel

Bloodstream infections caused ...... emiology, and clinical outcome

@ast

Bloodstream infections caused ...... emiology, and clinical outcome

@en

Bloodstream infections caused ...... emiology, and clinical outcome

@nl

P1433

Q34351978-04BA9A86-A871-4102-B1C9-8E6BD8389DC1

P1476

Q34351978-8B342C2E-B8A3-48A5-A91C-0E0FC64675A7

P2093

Q34351978-13528775-CA0D-4125-8C9C-392FB0656D9C

Q34351978-466A2C8A-11AE-4ADE-968B-B569160D3B6B

Q34351978-5D7833AD-FAEC-4984-9DA2-5A6BDA2BE87D

Q34351978-674B0377-2735-4EE5-B73C-06C690388278

Q34351978-8FB25FCC-C726-44F4-B468-6613DA71C31E

Q34351978-D8D6D00D-89DB-4219-86C3-BBE75D83A2FD

P2860

Q34351978-0153330F-D019-473D-A955-493EC207D5C4

Q34351978-05CDE53B-BC30-4467-A9E3-FD2C890D3011

Q34351978-115B95EF-9928-49ED-A3D4-58684EA82B76

Q34351978-12F67476-24B1-4EF7-9DA1-D6D68D89B179

Q34351978-23F1AED9-B782-458C-9374-B26E1BA5B3A0

Q34351978-2D110415-5D8E-4BE6-A651-8636774C4554

Q34351978-2FD0F22D-1EE4-44DB-AD17-0139CCA9D11A

Q34351978-31DC6EA6-5A53-4D16-AE0A-9423472590EA

Q34351978-3379422F-1A2B-42D5-A177-BA1F14875323

Q34351978-39492D2F-3935-499C-B60B-7A1D64D8F65E

P304

Q34351978-65DAEC73-61EF-4B8B-A8B6-54F660917E3F

P31

Q34351978-1558CEEF-7578-4BBA-8731-6000DF5F500A

P356

Q34351978-0A1F3819-9336-4947-AC50-9901008FF08B

P407

Q34351978-B6E7ADCB-80A0-4E84-8D1E-96D40AB2D027

P433

Q34351978-F6C3A71D-9355-444A-889D-1A365B015BC5

P478

Q34351978-12F623E9-103A-4993-AC08-FBD6093B4B49

P50

Q34351978-08EE52CB-51EE-44DB-8058-B3F3090C6B10

Q34351978-50C7317E-9937-4FDE-8C2E-0E3133A2061C

P577

Q34351978-BAEC1978-ED23-433C-87F4-8CFC2B0E608A

P5875

Q34351978-05D712E2-EE1A-4A34-85E6-EF4B32FE3B50

P698

Q34351978-54293A14-44F9-4879-AE60-2022503A0EEC

P921

Q34351978-33C17038-F5D9-45BC-97AC-8A824C991100

Q34351978-9716E212-F542-40A9-BA5E-3947954210B4

P932

Q34351978-335C202B-382F-47F4-97E9-C1FEC96805A5

P356

AAC.50.2.498-504.2006

P1433

Antimicrobial Agents and Chemotherapy

P1476

Bloodstream infections caused ...... emiology, and clinical outcome

@en

P2093

Eva Montuori

http://www.w3.org/2001/XMLSchema#string

Fiammetta Leone

http://www.w3.org/2001/XMLSchema#string

Giovanni Fadda

http://www.w3.org/2001/XMLSchema#string

Mario Tumbarello

http://www.w3.org/2001/XMLSchema#string

Rita Citton

http://www.w3.org/2001/XMLSchema#string

Teresa Spanu

http://www.w3.org/2001/XMLSchema#string

P2860

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors

Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases

beta-Lactamases in laboratory and clinical resistance

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Does high level production of SHV-type penicillinase confer resistance to ceftazidime in Enterobacteriaceae?

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

Risk factors for recovery of ampicillin-sulbactam-resistant Escherichia coli in hospitalized patients.

Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance.

Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs

P304

498-504

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.50.2.498-504.2006

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Maurizio Sanguinetti

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7336384

http://www.w3.org/2001/XMLSchema#string

P698

16436702

http://www.w3.org/2001/XMLSchema#string

P921

Klebsiella pneumoniae

P932

1366869

http://www.w3.org/2001/XMLSchema#string